William Blair Issues Negative Outlook for Biogen Earnings
Biogen Inc. (NASDAQ:BIIB – Free Report) – Investment analysts at William Blair dropped their Q2 2025 EPS estimates for Biogen in a research note issued to investors on Wednesday, April 23rd. William Blair analyst M. Minter now expects that the biotechnology company will post earnings of $4.10 per share for the quarter, down from their […]
